circBIRC6靶向miR-367-3p对卵巢癌细胞顺铂耐药的影响
体外研究探讨circBIRC6对卵巢癌细胞顺铂耐药性的影响及分子机制,发现SKOV3/DDP耐药细胞中circBIRC6表达高于SKOV3细胞,miR-367-3p表达低于SKOV3细胞;敲低circBIRC6可上调miR-367-3p,抑制耐药细胞增殖、诱导凋亡并降低顺铂耐药性。
要点
- SKOV3/DDP耐药细胞中circBIRC6表达高于SKOV3细胞,miR-367-3p表达低于SKOV3细胞。
- 敲低circBIRC6联合顺铂可提高SKOV3和SKOV3/DDP细胞增殖抑制率与凋亡率。
- 双荧光素酶实验证实circBIRC6靶向miR-367-3p,抑制miR-367-3p可减弱敲低circBIRC6的作用。
核心结论
- 抑制circBIRC6的表达可能通过上调miR-367-3p的表达而抑制卵巢癌顺铂耐药细胞增殖及诱导细胞凋亡,从而降低细胞对顺铂的耐药性。
研究设计与样本
- 体外培养卵巢癌细胞株SKOV3和卵巢癌顺铂耐药细胞株SKOV3/DDP,采用脂质体介导法转染si-NC、si-circBIRC6、si-circBIRC6+anti-miR-NC或si-circBIRC6+anti-miR-367-3p,并加入2 μg/ml顺铂处理24 h。
- 采用四甲基偶氮唑蓝法检测细胞增殖抑制率并计算顺铂IC(50)值,实时荧光定量PCR检测circBIRC6和miR-367-3p表达,流式细胞术检测凋亡率,双荧光素酶报告实验验证靶向关系,Western blot检测Cyclin D1、Bcl-2、p21、Bax蛋白表达。
主要发现
- SKOV3细胞中circBIRC6表达水平为1.00±0.05,低于SKOV3/DDP细胞的3.04±0.24(P<0.001)。
- SKOV3细胞中miR-367-3p表达水平为1.00±0.08,高于SKOV3/DDP细胞的0.54±0.05(P<0.001)。
- SKOV3细胞和SKOV3/DDP细胞的增殖抑制率分别为(22.47±2.04)%和(8.84±0.71)%,IC(50)值分别为6.65±0.94和28.18±4.91,差异均有统计学意义(均P<0.05)。
- DDP+si-circBIRC6组SKOV3细胞增殖抑制率和凋亡率分别为(74.18±5.36)%和(32.91±3.19)%,高于DDP+si-NC组的(22.19±2.19)%和(10.98±1.12)%(均P<0.05)。
- DDP+si-circBIRC6组SKOV3/DDP细胞增殖抑制率和凋亡率分别为(40.85±4.07)%和(25.31±2.53)%,高于DDP+si-NC组的(8.71±0.87)%和(7.39±0.63)%(均P<0.05)。
关键数值与推荐
- DDP+si-circBIRC6组SKOV3和SKOV3/DDP细胞中Cyclin D1和Bcl-2蛋白表达水平低于DDP+si-NC组,p21和Bax蛋白表达水平高于DDP+si-NC组(均P<0.05)。
- 双荧光素酶报告实验显示miR-367-3p为circBIRC6的靶基因,抑制miR-367-3p的表达可降低抑制circBIRC6表达对卵巢癌细胞增殖、凋亡及顺铂耐药性的作用。
临床怎么用
- 该研究为体外细胞实验,提示circBIRC6/miR-367-3p轴可能作为卵巢癌顺铂耐药的潜在干预靶点,尚需进一步转化验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the effect of circBIRC6 on cisplatin resistance of ovarian cancer cells and the molecular mechanism. Methods: The ovarian cancer cell line SKOV3 and ovarian cancer cisplatin-resistant cell line SKOV3 / DDP were cultured in vitro, and treated with different concentrations of cisplatin. SKOV3 and SKOV3/DDP cells were transfected with si-NC, si-circBIRC6, si-circBIRC6+ anti-miR-NC, si-circBIRC6+ anti-miR-367-3p by liposome-mediated method, which were denoted as DDP+ si-NC group, DDP+ si-circBIRC6 group, DDP+ si-circBIRC6+ anti-miR-NC group and DDP+ si-circBIRC6+ anti-miR-367-3p group, respectively, and then were treated with 2 μg/ml cisplatin for 24 hours. The cell proliferation inhibition rate was detected by 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H tetrazolium bromide method, and the half inhibitory concentration (IC(50)) value of cisplatin was calculated. Real-time fluorescent quantitative polymerase chain reaction was used to detect the transcriptional levels of circBIRC6 and miR-367-3p. Flow cytometry was used to detect the apoptotic rate. Dual luciferase report experiment verified the targeting relationship of circBIRC6 and miR-367-3p. Western blot was used to detect the expressions of Cyclin D1, Bcl-2, p21, Bax. Results: The expression levels of circBIRC6 in SKOV3 cells were 1.00±0.05, significantly lower than 3.04±0.24 in SKOV3/DDP cells (P<0.001). The expression levels of miR-367-3p in SKOV3 cells were 1.00±0.08, significantly higher than 0.54±0.05 in SKOV3/DDP cells (P<0.001). The cell proliferation inhibition rates of SKOV3 cells and SKOV3/DDP cells were (22.47±2.04)% and (8.84±0.71)%, the IC(50) values of SKOV3 cells and SKOV3/DDP cells were 6.65±0.94 and 28.18±4.91, respectively, with significant difference (P<0.05). The proliferation inhibition rate and apoptosis rate of SKOV3 cells in DDP+ si-NC group[(22.19±2.19)% and (10.98±1.12)%] were lower than those in DDP+ si-circBIRC6 group [(74.18±5.36)% and (32.91±3.19)%, all P<0.05]. The proliferation inhibition rate and apoptosis rate of SKOV3/DDP cells[(8.71±0.87)% and (7.39±0.63)%] were lower than those of DDP+ si-circBIRC6 group [(40.85±4.07)% and (25.31±2.53)%, all P<0.05]. The protein expression levels of Cyclin D1 and Bcl-2 in SKOV3 and SKOV3/DDP cells in DDP+ si-circBIRC6 group were lower than those in DDP+ si-NC group, and the protein expression levels of p21 and Bax were higher than those in DDP+ si-NC group (all P<0.05). The dual luciferase report experiment confirmed that circBIRC6 targeted miR-367-3p. Inhibition of miR-367-3p expression reduced the effect of circBIRC6 deletion on ovarian cancer cell proliferation, apoptosis and cisplatin resistance. Conclusion: Knockdown of circBIRC6 may inhibit the proliferation of ovarian cancer cisplatin-resistant cells and induce apoptosis by up-regulating the expression of miR-367-3p, therefore impair the cisplatin resistance of these cells. 目的: 探讨circBIRC6对卵巢癌细胞顺铂耐药性的影响及其分子机制。 方法: 体外培养卵巢癌细胞株SKOV3、卵巢癌顺铂耐药细胞株SKOV3/DDP,采用脂质体介导法将si-NC、si-circBIRC6、si-circBIRC6+anti-miR-NC、si-circBIRC6+anti-miR-367-3p转染至SKOV3和SKOV3/DDP细胞,分别记作DDP+si-NC组、DDP+si-circBIRC6组、DDP+si-circBIRC6+anti-miR-NC组和DDP+si-circBIRC6+anti-miR-367-3p组,各组细胞中分别加入2 μg/ml的顺铂处理24 h。采用四甲基偶氮唑蓝法检测细胞增殖抑制率,计算顺铂半数抑制浓度(IC(50))值,实时荧光定量聚合酶链反应检测circBIRC6、miR-367-3p的基因表达水平,流式细胞术检测细胞凋亡率,双荧光素酶报告实验验证circBIRC6、miR-367-3p的靶向关系,Western blot法检测细胞周期蛋白1(Cyclin D1)、Bcl-2、p21、Bax蛋白的表达水平。 结果: SKOV3细胞中circBIRC6的表达水平为1.00±0.05,低于SKOV3/DDP细胞(3.04±0.24,P<0.001);SKOV3细胞中miR-367-3p的表达水平为1.00±0.08,高于SKOV3/DDP细胞(0.54±0.05,P<0.001)。SKOV3细胞、SKOV3/DDP细胞增殖抑制率分别为(22.47±2.04)%和(8.84±0.71)%,IC(50)值分别为6.65±0.94和28.18±4.91,差异均有统计学意义(均P<0.05)。DDP+si-NC组SKOV3细胞增殖抑制率和细胞凋亡率[(22.19±2.19)%和(10.98±1.12)%]低于DDP+si-circBIRC6组[(74.18±5.36)%和(32.91±3.19)%,均P<0.05];DDP+si-NC组SKOV3/DDP细胞增殖抑制率和细胞凋亡率[(8.71±0.87)%和(7.39±0.63)%]低于DDP+si-circBIRC6组[(40.85±4.07)%和(25.31±2.53)%,均P<0.05]。DDP+si-circBIRC6组SKOV3、SKOV3/DDP细胞中Cyclin D1和Bcl-2蛋白表达水平低于DDP+si-NC组,p21和Bax蛋白表达水平高于DDP+si-NC组(均P<0.05)。双荧光素酶报告实验显示,miR-367-3p为circBIRC6的靶基因,抑制miR-367-3p的表达可降低抑制circBIRC6的表达对卵巢癌细胞增殖、凋亡及顺铂耐药性的作用。 结论: 抑制circBIRC6的表达可能通过上调miR-367-3p的表达而抑制卵巢癌顺铂耐药细胞增殖及诱导细胞凋亡,从而降低细胞对顺铂的耐药性。.
引用
- Zhang J, Bai HJ. [Effect of circBIRC6 targeting miR-367-3p on cisplatin resistance of ovarian cancer cells]. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34695896. doi:10.3760/cma.j.cn112152-20200427-00384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。